IL149281A0 - Treatment of cancer - Google Patents

Treatment of cancer

Info

Publication number
IL149281A0
IL149281A0 IL14928100A IL14928100A IL149281A0 IL 149281 A0 IL149281 A0 IL 149281A0 IL 14928100 A IL14928100 A IL 14928100A IL 14928100 A IL14928100 A IL 14928100A IL 149281 A0 IL149281 A0 IL 149281A0
Authority
IL
Israel
Prior art keywords
cancer
treatment
Prior art date
Application number
IL14928100A
Other languages
English (en)
Original Assignee
Unisearch Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unisearch Ltd filed Critical Unisearch Ltd
Publication of IL149281A0 publication Critical patent/IL149281A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/317—Chemical structure of the backbone with an inverted bond, e.g. a cap structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL14928100A 1999-10-26 2000-10-26 Treatment of cancer IL149281A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ3676A AUPQ367699A0 (en) 1999-10-26 1999-10-26 Treatment of cancer
PCT/AU2000/001315 WO2001030394A1 (en) 1999-10-26 2000-10-26 Treatment of cancer
US10/133,226 US20030203864A1 (en) 1999-10-26 2002-04-26 Treatment of cancer

Publications (1)

Publication Number Publication Date
IL149281A0 true IL149281A0 (en) 2002-11-10

Family

ID=30771561

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14928100A IL149281A0 (en) 1999-10-26 2000-10-26 Treatment of cancer

Country Status (9)

Country Link
US (1) US20030203864A1 (xx)
EP (1) EP1225919A4 (xx)
JP (1) JP2003512442A (xx)
CN (1) CN1414865A (xx)
AU (1) AUPQ367699A0 (xx)
CA (1) CA2388998A1 (xx)
IL (1) IL149281A0 (xx)
WO (1) WO2001030394A1 (xx)
ZA (1) ZA200203166B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003060516A1 (fr) * 2002-01-10 2003-07-24 Takeda Chemical Industries, Ltd. Methode de criblage
EP1909803A4 (en) * 2005-06-28 2010-09-29 Johnson & Johnson Res Pty Ltd GUANOSOLE OLIGONUCLEOTIDES AS ACTIVE AGENTS FOR CELL TODINDUCATION IN EUKARYOTIC CELLS
KR101600333B1 (ko) * 2014-09-29 2016-03-07 고려대학교 산학협력단 Egr-1 저해를 통한 아토피 피부염 치료제의 스크리닝 방법
CN104857529A (zh) * 2015-05-20 2015-08-26 山西大学 Egr-1基因在制备抗膀胱癌药物中的应用
GB201817990D0 (en) * 2018-11-02 2018-12-19 Univ Of Essex Enterprise Limited Enzymatic nucleic acid molecules
CN109706173A (zh) * 2019-01-31 2019-05-03 齐齐哈尔大学 一种通过RNAi沉默Egr1基因降低肺癌细胞多药耐药性的载体pZSW-1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807718A (en) * 1994-12-02 1998-09-15 The Scripps Research Institute Enzymatic DNA molecules
AU707943B2 (en) * 1996-03-07 1999-07-22 Unisearch Limited Inhibition of proliferation of cells
AUPN855496A0 (en) * 1996-03-07 1996-04-04 Unisearch Limited Prevention of proliferation of vascular cells
US6008048A (en) * 1998-12-04 1999-12-28 Isis Pharmaceuticals Inc. Antisense inhibition of EGR-1 expression
AU4448700A (en) * 1999-02-05 2000-08-25 Eileen Adamson Suppression of transformation of cells by the transcription factor egr

Also Published As

Publication number Publication date
CN1414865A (zh) 2003-04-30
US20030203864A1 (en) 2003-10-30
CA2388998A1 (en) 2001-05-03
ZA200203166B (en) 2003-06-25
AUPQ367699A0 (en) 1999-11-18
EP1225919A1 (en) 2002-07-31
JP2003512442A (ja) 2003-04-02
WO2001030394A1 (en) 2001-05-03
EP1225919A4 (en) 2006-07-19

Similar Documents

Publication Publication Date Title
GB9903841D0 (en) Diagnosis and treatment of cancer
SI1176964T1 (sl) Uporaba et743 za zdravljenje raka
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
EP1320376A4 (en) TREATMENT OF PROSTATE CANCER
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
NZ513686A (en) Treatment of trauma
AU9402401A (en) Treatment of cancers
IL149281A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
GB9819999D0 (en) Treatment of cancer
GB0026015D0 (en) Cancer treatment
NZ514016A (en) Treatment of osteoarthritis
GB9804361D0 (en) Cancer treatment
GB9911183D0 (en) Treatment of cancers
GB9927005D0 (en) Treatment of cancers
GB9918534D0 (en) Treatment of cancers
GB9911346D0 (en) Treatment of cancers
GB9908176D0 (en) Cancer treatment
GB9927106D0 (en) Cancer treatment
GB0008161D0 (en) Treatment of cancer
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor
GB9917181D0 (en) Methods of treatment
GB9901310D0 (en) Methods of treatment
GB0007254D0 (en) Treating cancer
GB9914971D0 (en) Treating cancer